Collaborative Care Joseph Parks, MD Medical Director - Missouri DMH - - PowerPoint PPT Presentation

collaborative care
SMART_READER_LITE
LIVE PREVIEW

Collaborative Care Joseph Parks, MD Medical Director - Missouri DMH - - PowerPoint PPT Presentation

Missouri : Making the Business Case for Collaborative Care Joseph Parks, MD Medical Director - Missouri DMH Director - Missouri Institute of Mental Health History > Chronic Care Improvement Program (CCIP) January, 2007- July 2008 >


slide-1
SLIDE 1

Missouri : Making the Business Case for Collaborative Care

Joseph Parks, MD Medical Director - Missouri DMH Director - Missouri Institute of Mental Health

slide-2
SLIDE 2

History

> Chronic Care Improvement Program (CCIP)

  • January, 2007- July 2008

> CMHC Care Coordination and Disease Management

(DMHNET)

  • July 2008 – January 2011

> DM 3700 Out Reach

  • November, 2010 - ongoing

> Health Care Homes

  • January 2011 - ongoing
slide-3
SLIDE 3

CCIP Statewide

> Community Mental Health Centers have approved 10% of the

healthcare home plans of care in the State Medicaid program.

> Care Coordination with more than 35,000 patient histories

have been reviewed in CyberAccess.

> More than 70% of patients have had a primary care visit

within a 12-month period, according to claims; sampled chart review indicates a higher percentage (3 agency sample over 90%).

> Outcomes review of Missouri Psychiatric Rehabilitation

programs indicates substantial off-trend cost savings for the

  • verall healthcare cost after admission to the program.
slide-4
SLIDE 4

CCIP CMHC DISEASE MANAGEMENT

> Clients were Medicaid enrolled with a CCIP

eligible medical diagnosis and a serious mental illness enrolled in a CMHC, but may

  • r may not have been enrolled in CCIP.

> Clients received Psychiatric Rehabilitation

services if they were eligible for those services.

> Average Medicaid annual medical cost for the

clients was $18,672 per year.

slide-5
SLIDE 5

A Typical Enrollee

> A 47 year old male > More than one major

targeted disease

> Likely has a major

cardiovascular diagnosis and diabetes

> Likely has experienced

a major cardiac event

> A third have a major

behavior health co- morbidity

> A generally motivated

cohort

Continuously Enrolled 7/1/2007 - 6/30/2008 Disease Number of Individuals Percentage

Asthma 9,817 39.7% CAD 16,982 68.8% CHF 5,746 23.3% COPD 8,155 33.0% Diabetes 12,939 52.4% GERD 12,592 51.0% Sickle Cell 558 2.3% Behavioral Disability 8,395 34.0% *Includes co-morbid conditions 24,700

4/25/2012

5

slide-6
SLIDE 6

Missouri CCIP Diabetes Outcomes

Hemoglobin A1c Compliance

47% 26% 12% 25% 0% 10% 20% 30% 40% 50% HbA1c - one or more tests HbA1c - two or more tests Clinical Measure Percent Compliant

ENROLLED N=12,939 NON-ENROLLED N=33,631

6

HbA1c testing provides an estimation of average blood glucose values in people with diabetes. Enrollees in the CCIP program received substantially more HbA1c testing than those not enrolled.

slide-7
SLIDE 7

Missouri CCIP Coronary Artery Disease (CAD) Outcomes

Beta Blocker Post MI Compliance

61% 33% 0% 10% 20% 30% 40% 50% 60% 70% Beta Blocker Post-AMI Clinical Measure Percent Compliant Enrolled N=16,982 Non Enrolled N=29,088

7

CCIP enrollees with coronary artery disease (CAD) received recommended treatment with beta blocker medications at nearly twice the rate of non-enrollees.

slide-8
SLIDE 8

Trend Analysis of Total Costs

MO HealthNet Average Total Monthly Costs for CCIP Disease Eligible Population

$- $200 $400 $600 $800 $1,000 $1,200 $1,400 $1,600 Jan-06 Feb-06 Mar-06 Apr-06 May-06 Jun-06 Jul-06 Aug-06 Sep-06 Oct-06 Nov-06 Dec-06 Jan-07 Feb-07 Mar-07 Apr-07 May-07 Jun-07 Jul-07 Aug-07 Sep-07 Oct-07 Nov-07 Dec-07 Jan-08 Feb-08 Mar-08 $ PMPM

Actual CCIP Enrolled Eligible-Not Enrolled Linear (Actual)

$1,283 PMPM $962 PMPM

Average Total Monthly Costs for CCIP-enrolled participants were below projection. March 2008 demonstrates a $321 PMPM savings.

slide-9
SLIDE 9

Trend Analysis of Emergency Room Utilization

ER Usage Rate per 1000

50 100 150 200 250 300 J a n

  • 6

F e b

  • 6

M a r

  • 6

A p r

  • 6

M a y

  • 6

J u n

  • 6

J u l

  • 6

A u g

  • 6

S e p

  • 6

O c t

  • 6

N

  • v
  • 6

D e c

  • 6

J a n

  • 7

F e b

  • 7

M a r

  • 7

A p r

  • 7

M a y

  • 7

J u n

  • 7

J u l

  • 7

A u g

  • 7

S e p

  • 7

O c t

  • 7

N

  • v
  • 7

D e c

  • 7

J a n

  • 8

F e b

  • 8

M a r

  • 8

Rate per 1000 Enrolled Identified, Not Enrolled Identified Linear (Identified)

Projection Achieved ER reduction ~30%

4/25/2012 9

ER visits decreased more substantially than projected representing another key cost driver for savings

slide-10
SLIDE 10

Cost Savings for clients in CMHCs

Base Period (CY2006) $1,556 Expected Trend 16.67% Expected Trend with no Intervention $1,815.81 Actual PMPM in Performance Period (FY2007) $1,504.34 Gross PMPM Cost Savings $311.47 Lives 6,757 Gross Program Savings $25,254,928 Vendor Fees $1,301,560 Net Program Savings $23,953,368 NET PMPM Program Savings $295.41 Net Program Savings/(Cost) as percentage of Expected PMPM 16.3%

slide-11
SLIDE 11

CMHC Savings Off Trend

Category pre CMHC-CM post CMHC-CM Net Change Percent Change Pharmacy $39,367,496 $30,154,143 ($9,213,352)

  • 23.4%

General Hospital $23,140,172 $21,546,466 ($1,593,706)

  • 6.9%

Psych Rehab $35,378,951 $37,467,731 $2,088,780 5.9% Psychologist $463,069 $144,434 ($318,635)

  • 68.8%

Independent Clinic $3,549,715 $4,324,452 $774,738 21.8% Overall $101,899,402 $93,637,226 ($8,262,176)

  • 16.%
slide-12
SLIDE 12

Medicaid Cost Savings for the 6,757 people

> OFF TREND SAVINGS OF $25 million annually. > Actual Pharmacy services decreased by $9.2 million

annually or 23%

> Actual General Hospital services decreased by $1.5

million or 6.8%

> Actual Primary Caare services increased by

$774,000 or 21%

slide-13
SLIDE 13

DMHNET HEIDIS Indicators

> DM1: Use of inhaled corticosteroid medications by persons with

a history of COPD (chronic obstructive pulmonary disease) or Asthma.

> DM2: Use of ARB (angiotensin II receptor blockers) or ACEI

(angiotensin converting enzyme inhibitors) medications by persons with a history of CHF (congestive heart failure).

> DM3: Use of beta-blocker medications by persons with a history

  • f CHF (congestive heart failure).

> DM4: Use of statin medications by persons with a history of

CAD (coronary artery disease).

> DM5: Use of H2A (histamine 2-receptor antagonists) or PPI

(proton pump inhibitors) medications for no more than 8 weeks by persons with a history of GERD (gastro-esophageal reflux disease).

slide-14
SLIDE 14

DMH NET Results

> Provide specific lists of CMHC clients with care gaps

as identified by HEIDIS indicators to CMHC primary care nurse liaisons quarterly

> Provide HEIDIS indicator/disease state training on

standard of care to CMHC MH case managers

> First quarter focus on indicator one-asthma

substantially reduced percentage with care gap

  • Range 22% - 62% reduction
  • Median 45% reduction
slide-15
SLIDE 15

Total Healthcare Cost Trend Pre-/Post CMHC Enrollment

> Selection Criteria – 636 persons identified

  • Newly enrolled in CMHC case management
  • At least nine months of Medicaid claims in each of the

preceding two years and two years following CMHC enrollment

> Methodology

  • Calculate total monthly Medicaid costs PMPM 424 months

pre and post-enrollment

  • month zero is 24 months prior to enrollment, month 24 is the

month of enrollment, 148 is 24 months after enrollment

  • Calculate linear regression trend lines
slide-16
SLIDE 16

Total HealthCare Utilization Per User Per Month Pre and Post Community Mental Health Case Management

Months with case management initiated on month 24 Average Medicaid expenditures per month

slide-17
SLIDE 17

CMHC Outcomes comparing admission to annual assessments

> Independent Living increased by 33% > Vocational Activity increased by 44% > Legal Involvement decreased by 68% > Psychiatric Hospitalization decreased by 52% > Illegal Substance use decreased by 52% > IN ADDITION- Study shows CMHCs services

substantially decrease overall medical cost

slide-18
SLIDE 18

Disease Management 3700 Initiative

> DM 3700 is a collaborative, two-year project

between the DMH and MO HealthNet, beginning November 1, 2010.

> Targets high cost Medicaid consumers who

have a chronic physical health condition and an identified mental health condition.

Analysis of Care Management

slide-19
SLIDE 19

> old model

  • Client, family, or healthcare referral makes a

call if the consumer seeks services, and they have to be evaluated for eligibility to receive services.

> New Model

  • High cost, high risk outreach to

selected consumers that the payer has selected for services.

Analysis of Care Management

Change in Business Model

slide-20
SLIDE 20

Old Model

slide-21
SLIDE 21

NEW Model

slide-22
SLIDE 22

Target Population

> $25,000 minimum cost for previous 12 months or risk

predicted to have high cost

> A diagnosis of schizophrenia, schizoaffective disorder, bipolar

disorder, or recurrent major depression

> Not a consumer of public mental health system in previous 12

months

> Excluded nursing home, developmental disability, hospice and

renal failure

> Average cost of group over $50,000 per year

Analysis of Care Management

slide-23
SLIDE 23

Physical Health Demographic 35% COPD 34% Asthma 32% Diabetes 11% Congestive Heart Failure (CHF)

Analysis of Care Management

slide-24
SLIDE 24

Cost Savings Including Cost of Intervention

> 1298 clients enrolled for over 6 months

  • $346 PMPM actual cost savings
  • $5.4 Million annualized
  • $619 PMPM trended cost savings
  • $9.6 Million annualized

DM 3700 Progress

slide-25
SLIDE 25

Discussion

slide-26
SLIDE 26

Discussion